Jane Street’s Structure Therapeutics GPCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$7.28M Buy
+232,677
New +$10.9M ﹤0.01% 3207
2026
Q1
– Sell
-147,217
Closed -$10.1M – 12101
2025
Q4
$10.2M Buy
+147,217
New +$6.01M ﹤0.01% 2290
2025
Q2
– Sell
-120,703
Closed -$2.65M – 10102
2025
Q1
$2.09M Buy
120,703
+4,690
+4% +$115K ﹤0.01% 4277
2024
Q4
$3.15M Buy
116,013
+77,176
+199% +$2.74M ﹤0.01% 3361
2024
Q3
$1.7M Sell
38,837
-70,318
-64% -$2.72M ﹤0.01% 4808
2024
Q2
$4.29M Buy
109,155
+101,485
+1,323% +$4.17M ﹤0.01% 3215
2024
Q1
$329K Sell
7,670
-31,128
-80% -$1.31M ﹤0.01% 7409
2023
Q4
$1.58M Buy
+38,798
New +$2.22M ﹤0.01% 4743

Other funds holding GPCR

Jane Street's GPCR Position: Q3 2026 in Review

Jane Street opened a new position in Structure Therapeutics (GPCR) in Q3 2026: 232,677 shares worth $7.28M. The stake represents ﹤0.01% of the portfolio and ranks #3207 among its holdings. This is a return to the name: Jane Street previously reported a position in GPCR as recently as Q4 2025.

Jane Street first reported a position in GPCR in Q4 2023 and has held it in 8 quarters since. The position peaked at $10.2M in Q4 2025. 172 funds tracked by Wall St. Rank hold GPCR as of Q3 2026.

  • Jane Street held 232,677 shares of Structure Therapeutics worth $7.28M as of Q3 2026.
  • Structure Therapeutics was a new Jane Street position in Q3 2026.
  • Structure Therapeutics made up ﹤0.01% of Jane Street's portfolio in Q3 2026, its #3207 holding.
  • Jane Street first reported a position in Structure Therapeutics in Q4 2023 and has held it in 8 quarters since.
  • Jane Street's Structure Therapeutics position peaked at $10.2M in Q4 2025.
  • 172 funds tracked by Wall St. Rank held Structure Therapeutics as of Q3 2026.

Based on Jane Street's 13F filing for Q3 2026, filed 12 Nov 2026.